SEC Filings | BioLineRx

Filing Date	Form	Description	View
Feb 13, 2019	EFFECT	EFFECT	9999999995-19-000214.rtf 9999999995-19-000214.xls 9999999995-19-000214.pdf
Feb 11, 2019	UPLOAD	UPLOAD	0000000000-19-001705.rtf 0000000000-19-001705.pdf
Feb 11, 2019	CORRESP	CORRESP	0001178913-19-000365.rtf 0001178913-19-000365.xls 0001178913-19-000365.pdf
Feb 08, 2019	SC 13G/A	An amendment to the SC 13G filing	0000902664-19-000732.rtf 0000902664-19-000732.xls 0000902664-19-000732.pdf
Feb 08, 2019	SC 13G	A statement of beneficial ownership of common stock by certain persons	0000902664-19-000752.rtf 0000902664-19-000752.xls 0000902664-19-000752.pdf
Feb 07, 2019	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	0001178913-19-000335.rtf 0001178913-19-000335.xls 0001178913-19-000335.pdf
Feb 05, 2019	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	0001178913-19-000266.rtf 0001178913-19-000266.xls 0001178913-19-000266.pdf
Feb 05, 2019	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	0001178913-19-000289.rtf 0001178913-19-000289.xls 0001178913-19-000289.pdf
Feb 04, 2019	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	0001178913-19-000231.rtf 0001178913-19-000231.pdf
Feb 04, 2019	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	0001178913-19-000257.rtf 0001178913-19-000257.xls 0001178913-19-000257.pdf

Data provided by Kaleidoscope.